PAD Detection Right in Your Office.
The first step in successfully managing or treating PAD is detecting it. The FLOCHEC™ Digital ABI is a four-minute in-office test that provides a pulse waveform, digital ABI, and blood flow index on site. This allows you to discuss results with your patients immediately and treat or refer them to a specialist as needed. The FLOCHEC™ Digital ABI can be used to check patients with skin ulcerations and discolorations, follow changes in diabetics and others at risk for PAD, and to evaluate patients pre and post-intervention.
The majority of PAD cases may go undetected. PAD has historically been under-detected because expensive equipment and specialized personnel were required to perform an ABI test.
How it Works
IR light is transmitted into the digits and a sensor measures the reflected light which correlates with the volume of blood in the arteries and blood flow. A simple ratio of leg to arm flow is reported as an index.
Indications for Use: To monitor relative blood flow changes distal to the occlusion of a brachial, radial, ulnar, or femoral artery. From the physician history and clinical findings, the person has pain, claudication, or changes in blood flow to an extremity.
Contraindications: The device cannot be used on persons with no fingers or toes, or any person under 18 years of age.
Warning: The results may be subject to motion or movement artifacts. The device was not tested on patients with gross tremors.
Fourteen patients with 27 affected limbs had previously been diagnosed with PAD via ultrasound and/or angiography in one or both limbs.
Each patient was assessed first with a Doppler Ankle Brachial Index (ABI) and then with the FLOCHEC™ Digital ABI after a light exercise protocol. Measurements with the FLOCHEC™ Digital ABI were made bilaterally at both index fingers and both big toes.
The FLOCHEC™ Digital ABI was comparable to standard ABI in terms of recognizing reductions in arterial flow to the lower extremities. The sensitivity of both the Doppler ABI and FLOCHEC™ System was 78%. FLOCHEC™ Digital ABI may have significant advantages in clinical practice in terms of applicability, reproducibility, and ease of use.
The opinions and clinical experiences presented herein are for informational purposes only. The results from this case study may not be predictive for all patients. Individual results may vary depending on a variety of patient specific attributes. The center staff received compensation for the time and effort in preparing the above case study for further use and distribution.
Stay abreast of new developments in the treatment of PAD. Stand with us to help change lives. Are you a referring physician looking to connect with an interventionalist in your area? Visit our Physician Finder.
Would you like to be notified of new developments in the treatment of PAD and help change lives?Join the Campaign.
You are entering a section of this website that is intended for healthcare providers. If you are a healthcare provider, please click 'Proceed' to continue.Proceed Cancel
This site is not intended as a substitute for professional medical care. Only your physician can diagnose and appropriately treat your symptoms. Please click 'Proceed' to continue.Proceed Cancel
These three words have the power to change lives. Between 8 to 10 million Americans are estimated to suffer from poor blood flow to the arms, legs and feet potentially leading to vascular disease, amputation or worse. Are you, or someone you know, suffering from Peripheral Arterial Disease (PAD)? Do you have pain in your legs when you walk at night, or even when resting? Do not ignore it. These warning signs are real and it’s time to get real help. Welcome to the LOVE YOUR LIMBS™ Campaign, by Bard Peripheral Vascular.